ARTA
RPRX

A.R.T. Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

A.R.T. Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-34,315
Closed -$55K – 1591
2016
Q2 		$55K Buy
+34,315
New +$65.8K ﹤0.01% 1259
2016
Q1 		– Sell
-182,501
Closed -$220K – 1942
2015
Q4 		$220K Buy
182,501
+163,339
+852% +$524K 0.01% 1187
2015
Q3 		$142K Buy
+19,162
New +$147K 0.01% 1216

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

A.R.T. Advisors's RPRX Position: Q3 2016 in Review

A.R.T. Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q3 2016, closing a stake of 34,315 shares — an estimated $55K sold.

A.R.T. Advisors first reported a position in RPRX in Q3 2015 and held it in 3 quarters. The position peaked at $220K in Q4 2015. 46 funds tracked by Wall St. Rank hold RPRX as of Q3 2016.

  • A.R.T. Advisors reported no remaining Repros Therapeutics Inc. position as of Q3 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 34,315 Repros Therapeutics Inc. shares in Q3 2016, an estimated $55K.
  • A.R.T. Advisors first reported a position in Repros Therapeutics Inc. in Q3 2015 and held it in 3 quarters.
  • A.R.T. Advisors's Repros Therapeutics Inc. position peaked at $220K in Q4 2015.
  • 46 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2016.

Based on A.R.T. Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.